Geisinger Recognized by American Heart Association

Geisinger has been recognized by the American Heart Association (AHA) and American Medical Association (AMA) for commitment to helping improve blood pressure and cholesterol control rates among adult patients.

Through participation in the AHA and AMA’s Target BP™ initiative, Geisinger has earned Gold-level recognition. The Gold award recognizes health care organizations that have 70 percent or more of their adult patient population with high blood pressure controlled.

Geisinger has also earned Gold-level recognition through participation in the AHA’s Check. Change. Control. Cholesterol™ initiative. The Gold award recognizes health care organizations that have 70 percent or more of their adult patient population at risk for atherosclerotic cardiovascular disease (ASCVD) appropriately managed with statin therapy.

“Our Primary Care teams are profoundly dedicated to preventing, identifying and treating chronic conditions. Their work around management of these conditions, such as high blood pressure and high cholesterol, is a testament to their practice and the patients they serve,” said Stacei Faust, quality program coordinator for Geisinger Care Gaps. “It’s an honor to be recognized for that work by the AHA and AMA, and my pleasure to work alongside these remarkable colleagues.”

Hypertension (high blood pressure) is a leading risk factor for heart attacks, strokes and preventable death in the United States. There are 116 million U.S. adults living with high blood pressure, and less than half of those people have it under control – making diagnosing and effectively managing hypertension critical.

Cardiovascular disease remains a leading cause of morbidity and mortality in the U.S., with an estimated 92.1 million adults having at least one type of cardiovascular disease that can lead to heart attack, stroke or death. The use of statin therapy for the prevention of ASCVD in many higher-risk patients is supported by an extensive body of evidence, but many patients who might benefit from this therapy go untreated or undertreated, according to the AHA.

“We recognize how important aggressive and early treatment of chronic conditions like hypertension and hyperlipidemia is in preventing disease progression and serious complications like heart attack, stroke and kidney disease,” said Cybele Pacheco, M.D., director of Community Medicine in Geisinger’s west region. “Prevention and team-based management of chronic diseases is our focus in Primary Care, and it shows the collaborative work among our Geisinger teams.”